About Novopharm

Novopharm Limited is a privately held global company with 1,600 employees in Canada and 3,000 worldwide.  The company began its operations in 1963 from a 2,000 square-foot warehouse in Don Mills, Ontario.

Novopharm has a product range in excess of 380 products and manufactures more than 4.3 billion tablets and capsules to fill more than 32 million prescriptions. The company has retained the top slot in terms of prescription utilisation for a number of consecutive years.

Besides Canada, the company's major market, Novopharm has achieved significant growth via exports to the United States, Europe, the Middle East, the Caribbean, Central America and the Pacific Rim. The company specialises in manufacturing and marketing of generic OTC products such as analgesics (for cough and cold), vitamins, minerals, herbals and vaccines. World wide, the company operates nine subsidiaries including Novopharm Biotech. The company owns a 114,000 square foot manufacturing facility in Montreal, Quebec.